HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Babita Rahar Selected Research

M 280

1/2016S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Babita Rahar Research Topics

Disease

5Hypoxia (Hypoxemia)
03/2020 - 01/2014
1Body Weight (Weight, Body)
03/2020
1Edema (Dropsy)
03/2020
1Inflammation (Inflammations)
01/2016

Drug/Important Bio-Agent (IBA)

3sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
03/2020 - 01/2014
2Oxygen (Dioxygen)IBA
03/2020 - 01/2014
1LipidsIBA
03/2020
1Biomarkers (Surrogate Marker)IBA
03/2020
12,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA
03/2020
1Free RadicalsIBA
03/2019
1Differentiation AntigensIBA
03/2018
1CalciumIBA
03/2018
1Monomeric GTP-Binding ProteinsIBA
01/2016
1Adenosine Triphosphate (ATP)IBA
01/2016
1NitratesIBA
01/2016
1Protein Kinase CIBA
01/2016
1Endothelin-1 (Endothelin 1)IBA
01/2016
1M 280IBA
01/2016
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2016
1Sphingosine-1-Phosphate ReceptorsIBA
01/2014